Volume : 10, Issue : 02, February – 2023

Title:

30.AN ASSESSMENT OF ASTHMATIC PATIENTS THROUGH VARIOUS DIAGNOSTIC EXAMINATIONS AN ASSESSMENT OF ASTHMATIC PATIENTS THROUGH VARIOUS DIAGNOSTIC EXAMINATIONS
‬

Authors :

Rohit Kumar, Dr. Shailesh Kumar Ghatuary, Sarika Chaturvedi, Mamta dubey, Kirti

Abstract :

Asthma is a major non communicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. Inflammation and narrowing of the small airways in the lungs cause asthma symptoms, which can be any combination of cough, wheeze, shortness of breath and chest tightness. Asthma affected an estimated 262 million people in 2019 (1) and caused 455 000 deaths. Inhaled medication can control asthma symptoms and allow people with asthma to lead a normal, active life. Asthma is a long-term condition affecting children and adults. The air passages in the lungs become narrow due to inflammation and tightening of the muscles around the small airways. This causes asthma symptoms such as cough, wheeze, and shortness of breath and chest tightness. These symptoms are intermittent and are often worse at night or during exercise. Other common triggers can make asthma symptoms worse. Triggers vary from person to person, but can include viral infections (colds), dust, smoke, fumes, changes in the weather, grass and tree pollen, animal fur and feathers, strong soaps and perfume. . Achievement of this goal requires the development of new tools including novel Antiasthmatic drugs and more efficacious drugs as well as an increased understanding of the disease. The aim of this study an assessment of asthmatic patients through various diagnostic examination in District hospital, Etawah (U.P).

Cite This Article:

Please cite this article in press Rohit kumaret al,An Assessment Of Asthmatic Patients Through Various Diagnostic Examinations.,Indo Am. J. P. Sci, 2023; 10 (02).

Number of Downloads : 10

References:

1. Public health agency of Canada: life and breath: respiratory disease in Canada. Ottawa, Ontario 2007, Available: http://www.phac-aspc.gc.ca/publicat/2007/lbrdc-vsmrc/index-eng.php Accessed July 15, 2010.
2. Kim and Mezza Allergy, Asthma & clinical immunology 2017 (SUPPl1):S2 http://www.aacijournal.com /content/7/S1/S2
3. Ekor, M., 2014. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacology. Vol. 4.
4. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2017. http://www.ginasthma.org. Accessed 19 Feb 2017.
5. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, Meng L, McGillivray D. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008; 152(4):476–480. doi: 10.1016/j.jpeds.2007.08.034. [PubMed] [CrossRef] [Google Scholar]
6. Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada, 1996–2005: a population study. Am J Epidemiol. 2010; 172(6):728–736. doi: 10.1093/aje/kwq189. [PubMed] [CrossRef] [Google Scholar]
7. Yang CL, To T, Foty RG, Stieb DM, Dell SD. Verifying a questionnaire diagnosis of asthma children using health claims data. BMC Pulm Med. 2011;11:52. doi: 10.1186/1471-2466-11-52. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125:S95–S102. doi: 10.1016/j.jaci.2009.10.047. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007; 30(3):452–456. doi: 10.1183/09031936.00165106. [PubMed] [CrossRef] [Google Scholar]
10. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ. 2009; 181(9):E181–E190. doi: 10.1503/cmaj.080612. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725. doi: 10.1038/nm.2678. [PubMed] [CrossRef] [Google Scholar]
12. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R, Jr, Castro M, Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC, Bleecker ER. National Heart, Lung, and Blood Institute’s Severe Asthma Research Program.
13. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010; 181(4):315–323. doi: 10.1164/rccm.200906-0896OC. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Stein RT, Martinez FD. Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev. 2004; 5(2):155–161. doi: 10.1016/j.prrv.2004.01.007. [PubMed] [CrossRef] [Google Scholar]
15. Chang TS, Lemanske RF, Jr, Guilbert TW, Gern JE, Coen MH, Evans MD, Gangnon RE, Page CD, Jackson DJ. Evaluation of the modified Asthma Predictive Index in high-risk preschool children. J Allergy Clin Immunol Pract. 2013;1(2):152–156. doi: 10.1016/j.jaip.2012.10.008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity. J Pediatr. 2000;137(6):762–768. doi: 10.1067/mpd.2000.110121. [PubMed] [CrossRef] [Google Scholar]
17. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, Meng L, McGillivray D. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008; 152(4):476–480. doi: 10.1016/j.jpeds.2007.08.034. [PubMed] [CrossRef] [Google Scholar]
18. GINA 2011, pp. 2–5
19. Jindal SK, ed. (2011). Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. p. 242. ISBN 978-93-5025-073-0. Archived from the original on 2016-04-24.
20. George RB (2005). Chest medicine: essentials of pulmonary and critical care medicine (5th ed.). Philadelphia: Lippincott Williams & Wilkins. p. 62. ISBN 978-0-7817-5273-2. Archived from the original on 2016-05-05.
21. British Guideline 2009, p. 14
22. GINA 2011, pp. 8–9
23. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, et al. (April 2007). “Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma”. American Journal of Respiratory and Critical Care Medicine. 175 (8): 783–790. Doi:10.1164/rccm.200511-1746OC. PMC 1899291. PMID 17204725.
24. Stapleton M, Howard-Thompson A, George C, Hoover RM, Self TH (2011). “Smoking and asthma”. Journal of the American Board of Family Medicine. 24 (3): 313–322. Doi:10.3122/jabfm.2011.03.100180. PMID 21551404. S2CID 3183714.
25. Hayes CE, Nuss HJ, Tseng TS, Moody-Thomas S (2015). “Use of asthma control indicators in measuring inhaled corticosteroid effectiveness in asthmatic smokers: a systematic review”. The Journal of Asthma. 52 (10): 996–1005. Doi:10.3109/02770903.2015.1065422. PMID 26418843. S2CID 36916271.
26. Jump up to:a b c Kew KM, Nashed M, Dulay V, Yorke J (September 2016). “Cognitive behavioural therapy (CBT) for adults and adolescents with asthma”. The Cochrane Database of Systematic Reviews. 2016 (9): CD011818. doi:10.1002/14651858.CD011818.pub2. PMC 6457695. PMID 27649894.
27. Paudyal P, Hine P, Theadom A, Apfelbacher CJ, Jones CJ, Yorke J, et al. (May 2014). “Written emotional disclosure for asthma”. The Cochrane Database of Systematic Reviews (5): CD007676. Doi:10.1002/14651858.CD007676.pub2. PMID 24842151.